Resultados de la búsqueda 11-20 of 7442 for ���������������������������������TALK:PC53���

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate how well bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ ...

  2. Hematología y oncología pediátrica - Ensayos clínicos - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The aim of this study is to examine the role of mast cell mediators in children with allergic disorders in a two part study. Part 1 of the ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to explore how using different terms (with or without the word cancer) to identify papillary thyroid cancer might ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

  6. Primary Progressive Aphasia and Apraxia of Speech Clinic in Minnesota Panorama general

    Speech therapy is an important part of your treatment. Mayo Clinic speech-language pathologists have special training to help people with PPA and PPAOS. They ...

  7. Primary progressive apraxia of speech (PPAOS) - Síntomas y causas - Mayo Clinic

    This speech disorder happens when the brain does not communicate properly with the muscles used for speech.

  8. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...